Inflammopharmacology

Introduction — The coxib controversies
pp. 331-341(11)
Author: Rainsford, K.D.

The use of NSAIDs in rheumatic disorders 2005: a global perspective
pp. 343-370(28)
Authors: Kean, Walter F.; Buchanan, W. Watson

The murky waters of the coxibs: a review of the current state of play
pp. 371-380(10)
Authors: Ostor, Andrew J.K.; Hazleman, Brian L.

The murky world of the COX-2-selective agents
pp. 381-393(13)
Authors: Bjarnason, Ingvar; Thjodleifsson, Bjarni

COX-2 controversy: where are we and where do we go from here?
pp. 395-402(8)
Authors: Khanna, Dinesh; Khanna, Puja P.; Furst, Daniel E.

Coxibs and their aftermath: an (opinionated) commentary, based on some historical viewpoints
pp. 403-417(15)
Author: Whitehouse, M.

COX-2 inhibitors: a story of greed, deception and death
pp. 419-425(7)
Author: Halpern, Georges M.